An engineered non-toxic superantigen increases cross presentation of hepatitis B virus nucleocapsids by human dendritic cells.
Virus like particles (VLPs) are potent immunogens capable of priming strong protective antibody responses due to their repetitive structural arrangement and affinity for specific B cell receptors. By contrast, T cell responses to VLPs can be weak due to inefficient uptake and processing by antigen p...
Main Authors: | Julie D McIntosh, Kristy Manning, Shilpa Chokshi, Nikolai V Naoumov, John D Fraser, P Rod Dunbar, John A Taylor |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3972192?pdf=render |
Similar Items
-
Clarifying the mechanism of superantigen toxicity.
by: John D Fraser
Published: (2011-09-01) -
Superantigens and Streptococcal Toxic Shock Syndrome
by: Thomas Proft, et al.
Published: (2003-10-01) -
Uptake and intracellular trafficking of superantigens in dendritic cells.
by: María B Ganem, et al.
Published: (2013-01-01) -
Staphylococcal Superantigens: Pyrogenic Toxins Induce Toxic Shock
by: Teresa Krakauer
Published: (2019-03-01) -
Staphylococcal superantigens in colonization and disease
by: Stacey X Xu, et al.
Published: (2012-04-01)